Paper21189340
Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis.
Vergidis P and 7 others. Antimicrob Agents Chemother, 2011. Cited by 80 papers, by iCite.
Cite this record
ConductScience Library. Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis. Papers, record 21189340. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21189340
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetamides | Major topic |
| Foreign Bodies | Major topic |
| Methicillin-Resistant Staphylococcus aureus | Major topic |
| Osteomyelitis | Major topic |
| Oxazolidinones | Major topic |
| Rifampin | Major topic |
| Vancomycin | Major topic |
| Animals | |
| Linezolid | |
| Male | |
| Microbial Sensitivity Tests | |
| Rats | |
| Rats, Wistar |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9605897 | Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. | JAMA | 1998 | https://conductscience.org/library/papers/9605897 | PubMed |
| 2 | 17292421 | Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. | J Surg Res | 2007 | https://conductscience.org/library/papers/17292421 | PubMed |
| 3 | 1336342 | Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1336342 | PubMed |
| 4 | 19109338 | Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus. | J Antimicrob Chemother | 2009 | https://conductscience.org/library/papers/19109338 | PubMed |
| 5 | 15900290 | Linezolid and rifampin: Drug interaction contrary to expectations? | Clin Pharmacol Ther | 2005 | https://conductscience.org/library/papers/15900290 | PubMed |
| 6 | 9758730 | Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms. | J Surg Res | 1998 | https://conductscience.org/library/papers/9758730 | PubMed |
| 7 | 16361330 | Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis. | J Antimicrob Chemother | 2006 | https://conductscience.org/library/papers/16361330 | PubMed |
| 8 | 15357035 | Linezolid therapy for orthopedic infections. | Mayo Clin Proc | 2004 | https://conductscience.org/library/papers/15357035 | PubMed |
| 9 | 19423469 | Efficacy and tolerability of linezolid in chronic osteomyelitis and prosthetic joint infections: a case-control study. | J Chemother | 2009 | https://conductscience.org/library/papers/19423469 | PubMed |
| 10 | 19692690 | Clinical practice. Infection associated with prosthetic joints. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19692690 | PubMed |
| 11 | 17410386 | Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections. | Eur J Clin Microbiol Infect Dis | 2007 | https://conductscience.org/library/papers/17410386 | PubMed |
| 12 | 17574788 | Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series. | Diagn Microbiol Infect Dis | 2007 | https://conductscience.org/library/papers/17574788 | PubMed |
| 13 | 2393259 | Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2393259 | PubMed |
| 14 | 16377667 | Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/16377667 | PubMed |
| 15 | 15705640 | Linezolid in the treatment of Gram-positive prosthetic joint infections. | J Antimicrob Chemother | 2005 | https://conductscience.org/library/papers/15705640 | PubMed |
| 16 | 17538551 | The challenge of treating biofilm-associated bacterial infections. | Clin Pharmacol Ther | 2007 | https://conductscience.org/library/papers/17538551 | PubMed |
| 17 | 11083654 | Linezolid therapy of Staphylococcus aureus experimental osteomyelitis. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/11083654 | PubMed |
| 18 | 7985998 | Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/7985998 | PubMed |
| 19 | 17888634 | Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). | Int J Antimicrob Agents | 2007 | https://conductscience.org/library/papers/17888634 | PubMed |
| 20 | 19075065 | Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19075065 | PubMed |
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42953237 | PET Imaging of Osteomyelitis with [68Ga]Ga-BP. | Chem Biomed Imaging | 2026 | https://conductscience.org/library/papers/42953237 | PubMed |
| 40277362 | Activity of contezolid against methicillin-resistant Staphylococcus aureus in a rat model of foreign body osteomyelitis. | Microbiol Spectr | 2025 | https://conductscience.org/library/papers/40277362 | PubMed |
| 37242643 | Prosthetic Joint Infections: Biofilm Formation, Management, and the Potential of Mesoporous Bioactive Glass as a New Treatment Option. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37242643 | PubMed |
| 37154699 | Eradication of Staphylococcus epidermidis within Biofilms: Comparison of Systemic versus Supratherapeutic Concentrations of Antibiotics. | Antimicrob Agents Chemother | 2023 | https://conductscience.org/library/papers/37154699 | PubMed |
| 37109771 | Efficacy of Silver Nanoparticles-Loaded Bone Cement against an MRSA Induced-Osteomyelitis in a Rat Model. | Medicina (Kaunas) | 2023 | https://conductscience.org/library/papers/37109771 | PubMed |
| 36275796 | Comparing the efficacy of different antibiotic regimens on osteomyelitis: A network meta-analysis of animal studies. | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/36275796 | PubMed |
| 35558882 | Role of Animal Models to Advance Research of Bacterial Osteomyelitis. | Front Vet Sci | 2022 | https://conductscience.org/library/papers/35558882 | PubMed |
| 35456063 | Biofilm Formation by Pathogenic Bacteria: Applying a Staphylococcus aureus Model to Appraise Potential Targets for Therapeutic Intervention. | Pathogens | 2022 | https://conductscience.org/library/papers/35456063 | PubMed |
| 35227086 | Animal experimental investigation on the efficacy of antibiotic therapy with linezolid, vancomycin, cotrimoxazole, and rifampin in treatment of periprosthetic knee joint infections by MRSA. | Bone Joint Res | 2022 | https://conductscience.org/library/papers/35227086 | PubMed |
| 35149955 | The crafty opponent: the defense systems of Staphylococcus aureus and response measures. | Folia Microbiol (Praha) | 2022 | https://conductscience.org/library/papers/35149955 | PubMed |
| 34755579 | Recent advances in the local antibiotics delivery systems for management of osteomyelitis. | Drug Deliv | 2021 | https://conductscience.org/library/papers/34755579 | PubMed |
| 34723626 | Activity of Omadacycline in Rat Methicillin-Resistant Staphylococcus aureus Osteomyelitis. | Antimicrob Agents Chemother | 2022 | https://conductscience.org/library/papers/34723626 | PubMed |
| 33977040 | Efficient Killing of Multidrug-Resistant Internalized Bacteria by AIEgens In Vivo. | Adv Sci (Weinh) | 2021 | https://conductscience.org/library/papers/33977040 | PubMed |
| 33163477 | Characterization of an Acute Rodent Osteomyelitis Infectious Model Using a Tibial Intramedullary Implant Inoculation. | Front Bioeng Biotechnol | 2020 | https://conductscience.org/library/papers/33163477 | PubMed |
| 32867208 | Antibiotic Tolerance of Staphylococcus aureus Biofilm in Periprosthetic Joint Infections and Antibiofilm Strategies. | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/32867208 | PubMed |
| 32285973 | Therapeutics and delivery vehicles for local treatment of osteomyelitis. | J Orthop Res | 2020 | https://conductscience.org/library/papers/32285973 | PubMed |
| 31740562 | Activity of Different Antistaphylococcal Therapies, Alone or Combined, in a Rat Model of Methicillin-Resistant Staphylococcus epidermidis Osteitis without Implant. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/31740562 | PubMed |
| 31518346 | Effects of a rifampicin pre-treatment on linezolid pharmacokinetics. | PLoS One | 2019 | https://conductscience.org/library/papers/31518346 | PubMed |
| 31036685 | Activity of Antibiotics against Staphylococcus aureus in an In Vitro Model of Biofilms in the Context of Cystic Fibrosis: Influence of the Culture Medium. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/31036685 | PubMed |
| 30813284 | Calcium Phosphate Spacers for the Local Delivery of Sitafloxacin and Rifampin to Treat Orthopedic Infections: Efficacy and Proof of Concept in a Mouse Model of Single-Stage Revision of Device-Associated Osteomyelitis. | Pharmaceutics | 2019 | https://conductscience.org/library/papers/30813284 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21189340
GET https://conductscience.org/api/papers/v1/21189340/references?page=2